Skip to Content
Merck
  • Real-time tracking of bioluminescent influenza A virus infection in mice.

Real-time tracking of bioluminescent influenza A virus infection in mice.

Scientific reports (2022-02-26)
Jin H Kim, Hannah Bryant, Edward Fiedler, TuAnh Cao, Jonathan O Rayner
ABSTRACT

Despite the availability of vaccines and antiviral therapies, seasonal influenza infections cause 400,000 human deaths on average per year. Low vaccine coverage and the occurrence of drug-resistant viral strains highlight the need for new and improved countermeasures. While influenza A virus (IAV) engineered to express a reporter gene may serve as a valuable tool for real-time tracking of viral infection, reporter gene insertion into IAV typically attenuates viral pathogenicity, hindering its application to research. Here, we demonstrate that lethal or even sublethal doses of bioluminescent IAV carrying the NanoLuc gene in the C-terminus of PB2 can be tracked in real-time in live mice without compromising pathogenicity. Real-time tracking of this bioluminescent IAV enables spatiotemporal viral replication tracking in animals that will facilitate the development of countermeasures by enhancing the interpretation of clinical signs and prognosis while also allowing less animal usage.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Influenza A Antibody, nucleoprotein, clone A3, clone A3, Chemicon®, from mouse
Sigma-Aldrich
Anti-Influenza A Antibody, nucleoprotein, clone A1, clone A1, Chemicon®, from mouse